Quarter-Century Transformation of Oncology: Positron Emission Tomography for Patients with Breast Cancer.
PET Clin
; 19(2): 147-162, 2024 Apr.
Article
em En
| MEDLINE
| ID: mdl-38177052
ABSTRACT
PET radiotracers have become indispensable in the care of patients with breast cancer. 18F-fluorodeoxyglucose has become the preferred method of many oncologists for systemic staging of breast cancer at initial diagnosis, detecting recurrent disease, and for measuring treatment response after therapy. 18F-Sodium Fluoride is valuable for detection of osseous metastases. 18F-fluoroestradiol is now FDA-approved with multiple appropriate clinical uses. There are multiple PET radiotracers in clinical trials, which may add utility of PET imaging for patients with breast cancer in the future. This article will describe the advances during the last quarter century in PET for patients with breast cancer.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Temas:
Geral
/
Tipos_de_cancer
/
Outros_tipos
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Ósseas
/
Neoplasias da Mama
Limite:
Female
/
Humans
Idioma:
En
Revista:
PET Clin
Ano de publicação:
2024
Tipo de documento:
Article